Showing results (1121-1130 of 6,793) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|June 6, 2006
Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month studyFiona Dunbar, Young Zhu, H Robert BrashearClinical Therapeutics|June 6, 2006
Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trialJoseph Colin, Bertrand PaquetteClinical Therapeutics|June 6, 2006
Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteersLesley A Houghton, Wendy Atkinson, Peter J Whorwell, et al.Clinical Therapeutics|January 1, 1991
Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study GroupClinical Therapeutics|September 1, 1991
A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation GroupClinical Therapeutics|September 1, 1991
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic propertiesM B Kays, R L White, L V Friedrich, et al.Clinical Therapeutics|March 24, 2009
The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysisPhilippa J Delahoy, Dianna J Magliano, Kate Webb, et al.Clinical Therapeutics|March 24, 2009
Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging studyLouis-Georges Ste-Marie, Jacques P Brown, John F Beary, et al.Clinical Therapeutics|March 24, 2009
Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid useJohn H Peniston, Errol GouldClinical Therapeutics|March 24, 2009
Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analoguesFeifei Wang, Honghai Wang, Hongbo Shen, et al.Pageof 680